Global Automated Cell Counters Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Automated Cell Counters Market is presumed to reach the market size of nearly USD 12.08 MN by 2030 from USD 7.3 MN in 2022 with a CAGR of 6.5% under the study period 2023 - 2030.

Automated cell counters are commonly used in laboratory tests to count cells. An automated cell counter is an electronic device that can automatically count the cells of animals, humans, plants, viruses, and bacteria, besides the cells of other origins. The cell counting process starts with loading a section into an automated cell counter, which is then passed over a narrow tube. Automated cell counters are intended to solve the challenges associated with manual cell counting. Automated cell counters are useful for determining blood cell concentrations, pathogen presence, harmful effects of drugs on model cells, etc.

MARKET DYNAMICS:

The increased frequency of illnesses such as HIV, measles, diphtheria, and chronic diseases such as cancer and other blood disorders is a significant factor driving the market growth. Moreover, advancements in image analysis software and informatics platforms in automated cell counters and growing funding for cell-based research drive the growth of automated cell counters. Also, technological development, along with major growth in the research industry, makes the automated cell counters market most lucrative globally. Furthermore, the rising access to healthcare, the advent of portable machines bringing in new patients, and the growing demand for healthcare services are expected to drive significant growth for the automated cell counters market. However, the high cost of cell analysis is expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of automated cell counters. The growth and trends of automated cell counters industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the automated cell counters market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Fluorescence Image-Based Cell Counter
Flow Cytometer
Coulter Counter

By Application

Blood Cells
Cell Lines
Microbial Cells
Others

By End-Use

Pharmaceutical & Biotechnology Companies
Hospitals
Diagnostic Laboratories
Research Institutes
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Automated Cell Counters market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Automated Cell Counters market include Olympus Corporation, Thermo Fisher Scientific Inc, Perkin Elmer Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, Sysmex Corporation, Nano EnTek, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc. and Radiometer), Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218505

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . AUTOMATED CELL COUNTERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AUTOMATED CELL COUNTERS MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Fluorescence Image-Based Cell Counter Historic and Forecast Sales by Regions
5.5 Flow Cytometer Historic and Forecast Sales by Regions
5.6 Coulter Counter Historic and Forecast Sales by Regions

6 . GLOBAL AUTOMATED CELL COUNTERS MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Blood Cells Historic and Forecast Sales by Regions
6.5 Cell Lines Historic and Forecast Sales by Regions
6.6 Microbial Cells Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL AUTOMATED CELL COUNTERS MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
7.5 Hospitals Historic and Forecast Sales by Regions
7.6 Diagnostic Laboratories Historic and Forecast Sales by Regions
7.7 Research Institutes Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL AUTOMATED CELL COUNTERS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE AUTOMATED CELL COUNTERS COMPANIES

9.1. Automated Cell Counters Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF AUTOMATED CELL COUNTERS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Olympus Corporation
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Thermo Fisher Scientific Inc
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Perkin Elmer Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Bio-Rad Laboratories Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Abbott Laboratories
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Sysmex Corporation
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Nano EnTek
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. F. Hoffmann-La Roche Ltd
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Danaher (Beckman Coulter Inc. and Radiometer)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Agilent Technologies Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies